Related Experiment Video
Updated: Jun 14, 2026

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion
Published on: February 2, 2021
Evidence-based management of patients undergoing PCI: contrast-induced acute kidney injury
Adriano Caixeta1, Roxana Mehran
1Columbia University Medical Center, Cardiovascular Research Foundation, New York, New York 10022, USA.
Insights
Contrast-induced acute kidney injury (CI-AKI) is a common hospital complication. Current prevention focuses on patient selection and hydration, with drug efficacy still under investigation.
Area of Science:
- Nephrology
- Radiology
- Cardiology
Background:
- Contrast-induced acute kidney injury (CI-AKI) is a significant cause of hospital-acquired kidney damage.
- High-risk patient groups include the elderly and those with chronic kidney disease, heart failure, or diabetes.
Purpose of the Study:
- To review current understanding and prevention strategies for CI-AKI.
- To highlight the controversies and future research needs regarding pharmacological interventions for CI-AKI.
Main Methods:
- Literature review of existing studies on CI-AKI.
- Analysis of risk factors and current preventative measures.
- Discussion of contrast agent properties and their nephrotoxicity.
Main Results:
- Effective CI-AKI prevention relies on careful patient selection, minimizing contrast volume, and adequate hydration.
- The efficacy of pharmacological agents in preventing CI-AKI remains largely unproven and debated.
- Nonionic, low-osmolar contrast media are recommended for high-risk individuals.
Conclusions:
- CI-AKI prevention requires a multi-faceted approach focusing on patient risk stratification and procedural optimization.
- Further research is essential to establish effective drug-based strategies for CI-AKI prevention.
- Choosing appropriate contrast agents is crucial for mitigating renal risk.
Abstract:
Contrast-induced acute kidney injury (CI-AKI) is one of the leading causes of hospital-acquired acute kidney injury. CI-AKI is highly prevalent in patients with well-known risk factors, including older age, chronic renal insufficiency, congestive heart failure, and diabetes. Thus far, no strategies have been shown to be effective in preventing CI-AKI beyond thorough patient selection, minimizing the amount of contrast agent, and meticulous hydration of the patient. The role of various drugs in preventing CI-AKI is still controversial and warrants future studies. Despite the remaining uncertainty regarding the degree of nephrotoxicity produced by various contrast agents, nonionic low-osmolar contrast media may be preferred in patients at high risk for CI-AKI.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury V: Interprofessional Care
Cardiac Catheterization I: Pre-Procedure Overview
Acute Kidney Injury I: Introduction
Acute Kidney Injury VI: Nursing Management
Imaging Studies VII: Vascular Imaging
